A transformative drug discovery and translational platform with advanced biomedical research and development capabilities.

LEARN MORE

BILL & MELINDA GATES FOUNDATION

We are excited about GHDDI’s potential to drive innovation in global health research and development, and look forward to partnering with Tsinghua University on our continued work to address the world’s most pressing global health challenges.

BILL GATES
Co-Chair of the Bill & Melinda Gates Foundation

TSINGHUA UNIVERSITY

The establishment of GHDDI is an important effort by Tsinghua University to advance pharmaceutical research and translational medicine. I hope this initiative will facilitate the reform of pharmaceutical R&D system in China and impact global health.

QIU YONG
PRESIDENT OF TSINGHUA UNIVERSITY

RESEARCH

GHDDI aims to become a major biomedical research center of excellence with a broad focus on translational research - from the bench to the bedside. Scientists at GHDDI work across a wide range of diseases that disproportionately affect populations in the developing world, including but not limited to tuberculosis, malaria, helminth infections, diarrheal disease, etc.

LEARN MORE

YOU CAN CREATE MORE POSSIBILITIES

We are seeking talented scientists and staff, as well as management and operations experts to join us!

JOIN US